NextCure, Inc. (NXTC) has 9 SEC Form 4 insider filings on record in the last 90 days. That includes 2 insider purchases totalling $1.7M, and 1 sales totalling $185K. Most recent filing: Aug. 12, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 12, 2026 filed Aug. 10, 2026 | Simcere Zaiming, Inc. Insider | −$184,800 | 30,000 | −9% | No | |
|
|
||||||
| Aug. 3, 2026 filed July 30, 2026 | ADAR1 Capital Management, LLC 10% Owner | +$1,624,121 | 329,153 | +84% | No | |
|
|
||||||
| July 29, 2026 filed July 27, 2026 | ADAR1 Capital Management, LLC 10% Owner | +$87,713 | 17,608 | +5% | No | |
|
|
||||||
| June 22, 2026 filed June 18, 2026 | Feigal Ellen Director | $0 | 2,340 | 0% | No | |
|
|
||||||
| June 22, 2026 filed June 18, 2026 | Jones Elaine V Director | $0 | 2,340 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 9 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free